n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with Melanoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ardon, E; Bar-Yehuda, S; Barer, F; Fishman, P; Madi, L; Ochaion, A | 1 |
Bar-Yehuda, S; Barer, F; Del Valle, L; Fishman, P; Khalili, K; Madi, L | 1 |
2 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and Melanoma
Article | Year |
---|---|
A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition.
Topics: Adenosine; Animals; Cell Division; Cell Line, Tumor; Cyclin D1; Down-Regulation; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Proteins; Neoplasms, Experimental; Protein Transport; Proto-Oncogene Proteins c-myc; Receptor, Adenosine A3; Signal Transduction | 2003 |
Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.
Topics: Adenosine; beta Catenin; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclins; Cytoskeletal Proteins; Down-Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinases; Humans; Melanoma; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Purinergic P1 Receptor Agonists; Signal Transduction; Trans-Activators; Tumor Cells, Cultured; Ubiquitin; Wnt Proteins; Zebrafish Proteins | 2002 |